NRAS and melanoma: Because the exact interplay between the HH-GLI pathway and MAPK signaling pathway is not yet understood, we decided to investigate the transcriptional targets of all three GLI proteins in melanoma with different genetic backgrounds, either harboring a BRAF mutation, an NRAS mutation, or no mutation in these two genes.